DD55034A - - Google Patents

Info

Publication number
DD55034A
DD55034A DD55034DA DD55034A DD 55034 A DD55034 A DD 55034A DD 55034D A DD55034D A DD 55034DA DD 55034 A DD55034 A DD 55034A
Authority
DD
German Democratic Republic
Application number
Publication of DD55034A publication Critical patent/DD55034A/xx

Links

DD55034D DD55034A (enExample)

Publications (1)

Publication Number Publication Date
DD55034A true DD55034A (enExample)

Family

ID=251385

Family Applications (1)

Application Number Title Priority Date Filing Date
DD55034D DD55034A (enExample)

Country Status (1)

Country Link
DD (1) DD55034A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096798A3 (fr) * 2003-04-25 2006-01-26 Sanofi Aventis Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096798A3 (fr) * 2003-04-25 2006-01-26 Sanofi Aventis Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique

Similar Documents

Publication Publication Date Title
US7777041B2 (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
EP1379504B1 (en) Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
JP2006524669A5 (enExample)
AU2002302511A1 (en) Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
DD55034A (enExample)